Literature DB >> 30169617

Electrocardiographic differentiation between 'benign T-wave inversion' and arrhythmogenic right ventricular cardiomyopathy.

Gherardo Finocchiaro1, Michael Papadakis1, Harshil Dhutia1, Abbas Zaidi1, Aneil Malhotra1, Elena Fabi2, Chiara Cappelletto2, Joe Brook1, Efstathios Papatheodorou1, Bode Ensam1, Christopher J Miles1, Rachel Bastiaenen3, Virginia Attard1, Tessa Homfray1, Rajan Sharma1, Maite Tome1, Gerald Carr-White3, Marco Merlo2, Elijah R Behr1, Gianfranco Sinagra2, Sanjay Sharma1.   

Abstract

AIMS: To characterize the most common electrocardiographic (ECG) abnormalities in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC), including anterior T-wave inversion (TWI) and to compare the characteristics of TWI in patients with ARVC and in a cohort of young healthy athletes and sedentary individuals. METHODS AND
RESULTS: The study population consisted of 162 patients with a definite diagnosis of ARVC and 129 young controls with anterior TWI. Cardiac disease was excluded in all controls after a comprehensive diagnostic work-up. The ECG was abnormal in 131 patients with ARVC (81%). Abnormalities included anterior TWI (n = 82, 51%), QRS duration ratio V2:V5 >1.2 (n = 51, 31%), prolonged terminal S wave activation duration in V2 >55 ms (n = 42, 26%), inferior TWI (n = 30, 18%), and lateral TWI (n = 26, 16%). The J-point preceding anterior TWI was <0.1 mV in 80/82 (98%) patients with ARVC and in 98 (76%) controls. Among the ARVC patients with anterior TWI, 62 (77%) showed at least one additional abnormal feature, most commonly QRS duration ratio V2:V5 > 1.2 (52%) and inferior or lateral TWI (47%).
CONCLUSION: The ECG is frequently abnormal in patients with ARVC and anterior TWI is the most common feature. Anterior TWI is usually accompanied by other abnormalities in ARVC, which are uncommon in healthy individuals. J point <0.1 mV preceding anterior TWI is not specific to ARVC and is observed in the majority of healthy individuals, including athletes, indicating a limited role for differentiating physiology or normal variants from ARVC.

Entities:  

Mesh:

Year:  2019        PMID: 30169617     DOI: 10.1093/europace/euy179

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  6 in total

Review 1.  Abnormal ECG Findings in Athletes: Clinical Evaluation and Considerations.

Authors:  Mark Abela; Sanjay Sharma
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-12-21

2.  Association of T-wave abnormalities with major cardiovascular events in diabetes: the ACCORD trial.

Authors:  Steven J Mould; Elsayed Z Soliman; Alain G Bertoni; Prashant D Bhave; Joseph Yeboah; Matthew J Singleton
Journal:  Diabetologia       Date:  2021-01-08       Impact factor: 10.122

Review 3.  The Female Athlete's Heart: Facts and Fallacies.

Authors:  Clea Simone S S Colombo; Gherardo Finocchiaro
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-11-03

Review 4.  Interpretation of T-wave inversion in physiological and pathological conditions: Current state and future perspectives.

Authors:  Flavio D'Ascenzi; Francesca Anselmi; Paolo Emilio Adami; Antonio Pelliccia
Journal:  Clin Cardiol       Date:  2020-04-07       Impact factor: 2.882

5.  Evaluating the 12-Lead Electrocardiogram for Diagnosing ARVC in Young Populations: Implications for Preparticipation Screening of Athletes.

Authors:  Cameron H Landry; Meena Fatah; Kim A Connelly; Paul Angaran; Robert M Hamilton; Paul Dorian
Journal:  CJC Open       Date:  2020-12-18

Review 6.  Dilated cardiomyopathy in the era of precision medicine: latest concepts and developments.

Authors:  Nicoletta Orphanou; Efstathios Papatheodorou; Aris Anastasakis
Journal:  Heart Fail Rev       Date:  2021-07-14       Impact factor: 4.654

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.